Valuation: Roopa Industries Limited

Market Cap 308M 3.23M 2.8M 2.61M 2.4M 4.55M 4.59M 30.76M 12.03M 154M 12.14M 11.87M 510M P/E 2024
30.6x
P/E 2025 19.8x
Enterprise Value 607M 6.37M 5.52M 5.15M 4.73M 8.96M 9.04M 60.58M 23.7M 303M 23.91M 23.38M 1B EV / Sales 2024
0.97x
EV / Sales 2025 0.58x
Free-Float
36.13%
Yield 2024 *
-
Yield 2025 -
1 week+0.46%
Current month-0.04%
1 month-0.02%
3 months-17.36%
6 months+4.12%
Current year+13.49%
1 week 47.14
Extreme 47.14
52
1 month 40
Extreme 40
53.6
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 37.4
Extreme 37.4
114.9
5 years 12.9
Extreme 12.9
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 1997-12-31
Director of Finance/CFO - 2020-06-30
Compliance Officer - 2022-05-31
Director TitleAgeSince
Chairman 72 1997-12-31
Director/Board Member 70 1997-03-16
Director/Board Member 70 2015-11-02
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.46%-11.27%+19.63% 4.12M
-0.51%-6.83%+46.35%+148.39% 1T
+0.20%-4.14%+52.35%+49.40% 613B
-0.53%-5.10%+24.88%+63.57% 433B
+0.48%-0.67%+39.13%+34.00% 350B
+0.08%-3.05%+32.29%+39.91% 292B
+2.09%-8.91%+5.73%+7.71% 239B
+1.75%-5.79%-0.39%-42.69% 206B
+2.94%+3.66%+31.37%+69.06% 204B
+3.13%+3.62%+19.50%+79.07% 163B
Average +0.71%-3.45%+23.99%+46.80% 350.05B
Weighted average by Cap. +0.66%-4.34%+35.20%+71.36%

Financials

2024 2025
Net sales 714M 7.49M 6.49M 6.05M 5.57M 10.53M 10.62M 71.23M 27.87M 356M 28.11M 27.49M 1.18B 1.21B 12.71M 11.02M 10.28M 9.45M 17.88M 18.03M 121M 47.31M 604M 47.72M 46.67M 2B
Net income 15.19M 159K 138K 129K 118K 224K 226K 1.52M 593K 7.57M 598K 585K 25.13M 20.35M 213K 185K 173K 159K 300K 303K 2.03M 794K 10.15M 801K 784K 33.66M
Net Debt 228M 2.39M 2.07M 1.93M 1.78M 3.36M 3.39M 22.72M 8.89M 114M 8.97M 8.77M 377M 299M 3.13M 2.72M 2.53M 2.33M 4.41M 4.45M 29.82M 11.67M 149M 11.77M 11.51M 494M
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
51
Date Price Change Volume
26-08-04 ₹49.98 0.00% 1
26-08-03 ₹49.98 -0.04% 538
26-07-31 ₹50.00 +4.12% 28
26-07-30 ₹48.02 -5.82% 199
26-07-28 ₹50.99 +2.49% 331
  1. Stock Market
  2. Stocks
  3. ROOPAIND6 Stock